AI Article Synopsis
- Metabolic syndrome (MetS) and type 2 diabetes (T2DM) are health issues that may be affected by the composition of gut microbiota, which is often overlooked in metabolic disease treatment.
- The review discusses the connection between probiotics/gut microbes and MetS development, emphasizing how supplementation can positively impact the onset of the condition.
- It also examines the role of dietary polyphenols (acting as prebiotics) in enhancing gut microbiota, highlighting the ongoing research and excitement around new microbial strains and their health benefits.
Article Abstract
Metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) are diseases that can be influenced by the structure of gut microbiota, whose improvement is often neglected in metabolic pathology. This review highlights the following main aspects: the relationship between probiotics/gut microbes with the pathogenesis of MetS, the particular positive roles of supplementation in the onset of MetS, and the interaction between dietary polyphenols (prebiotics) with gut microbiota. Therefore, an extensive and in-depth analysis of the often-neglected correlation between gut microbiota and chronic metabolic diseases was conducted, considering that this topic continues to fascinate and stimulate researchers through the discovery of novel strains and their beneficial properties.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002498 | PMC |
| http://dx.doi.org/10.3390/microorganisms9030618 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!